Clinical Trial Update: Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and efficacy of Rifamycin SV MMX for traveler’s diarrhea has completed and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traveler Diarrhea

Drugs mentioned

• Rifamycin SV MMX Multi-Matrix System (rifamycin SV)

Snippet

Sponsor: Cosmo Technologies Ltd | Conditions: Traveler's Diarrhea | Phase 3 | Status: COMPLETED | Results posted: 2018-04-10